Therascope AG brings in €24.1mm

Aug 2003

Small-molecule drug synthesis company Therascope AG has raised €24.1mm ($27.7mm) in a preferred-stock second round.

Biotechnology
- Drug Discovery Tools
  - Molecular Diversity
    - Natural Products
- Synthesis Technologies, Production Processes
Pharmaceuticals

Already a Strategic Transactions subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com

Related Companies

Therascope AG brings in €24.1mm

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice